ArticleCancer medicine2023

RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.

Xiandong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.